What is the equity of Nutex Befektetesi Nyrt this year?
Nutex Befektetesi Nyrt has equity of 5.3 B HUF this year.
In 2024, Nutex Befektetesi Nyrt's equity was 5.3 B HUF, a 2.58% increase from the 5.17 B HUF equity in the previous year.
Nutex Befektetesi Nyrt's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Nutex Befektetesi Nyrt's equity is essential for assessing its financial health, stability, and value to shareholders.
Evaluating Nutex Befektetesi Nyrt's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Nutex Befektetesi Nyrt's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Fluctuations in Nutex Befektetesi Nyrt’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Nutex Befektetesi Nyrt has equity of 5.3 B HUF this year.
The equity of Nutex Befektetesi Nyrt has increased/decreased by 2.58% increased compared to the previous year.
A high equity is advantageous for investors of Nutex Befektetesi Nyrt as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
A low equity can be a risk for investors of Nutex Befektetesi Nyrt, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
An increase in equity of Nutex Befektetesi Nyrt can strengthen the company's financial position and improve its ability to make investments in the future.
A reduction in equity of Nutex Befektetesi Nyrt can affect the financial situation of the company and lead to a higher dependence on debt capital.
Some factors that can affect the equity of Nutex Befektetesi Nyrt include profits, dividend payments, capital increases, and acquisitions.
The equity of Nutex Befektetesi Nyrt is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
To change equity, Nutex Befektetesi Nyrt can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
Over the past 12 months, Nutex Befektetesi Nyrt paid a dividend of 10 HUF . This corresponds to a dividend yield of about 68.26 %. For the coming 12 months, Nutex Befektetesi Nyrt is expected to pay a dividend of 0 HUF.
The current dividend yield of Nutex Befektetesi Nyrt is 68.26 %.
Nutex Befektetesi Nyrt pays a quarterly dividend. This is distributed in the months of .
Nutex Befektetesi Nyrt paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 HUF are expected. This corresponds to a dividend yield of 0 %.
Nutex Befektetesi Nyrt is assigned to the 'Health' sector.
To receive the latest dividend of Nutex Befektetesi Nyrt from 6/15/2011 amounting to 10 HUF, you needed to have the stock in your portfolio before the ex-date on 6/3/2011.
The last dividend was paid out on 6/15/2011.
In the year 2023, Nutex Befektetesi Nyrt distributed 0 HUF as dividends.
The dividends of Nutex Befektetesi Nyrt are distributed in HUF.
Our stock analysis for Nutex Befektetesi Nyrt Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nutex Befektetesi Nyrt Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.